openPR Logo
Press release

Non-Sterile Compounding Pharmacy Market Mega Trends 2018 | By Product - Oral Medication, Topical Medication, Otologic/Nasal Medication and Foreseeing to 2023

04-09-2018 11:24 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Non-Sterile Compounding Pharmacy Market

Non-Sterile Compounding Pharmacy Market

Non-Sterile Compounding Pharmacy Market is growing continuously and is expected to grow at a CAGR of 2.65% from 2017 to 2023. Compounding involves the customization of the medicine based on the physician prescription. The pharmacist customizes the dosage or strength and reformulates the drug by excluding unwanted ingredients to which the patient is allergic, or may change the form of the medicine for the patients who are unable to swallow the oral medications.

Non-Sterile Compounding Pharmacy Market: Key players  

Fagron (the Netherlands), B.Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), TRUE NATURE HOLDING, INC (U.S), Dougherty's Pharmacy Inc. (U.S.), and PHARMEDIUM (U.S.).

Ask for Sample Page @ https://www.marketresearchfuture.com/sample_request/4669 .

Segments:  

The U.S. & Europe non-sterile compounding pharmacy market is segmented into product, application, and end user. By type, the market is segmented into oral medication, topical medication, otologic/nasal medication, and others. The oral medications are further segmented into solid and liquid preparations. The topical medications include ointments, creams, gels, pastes, and others. By application, the market is segmented into pain medication, hormone replacement therapy, and others. By end user, the market is segmented into hospitals, compounding pharmacy, and others.

Non-Sterile Compounding Pharmacy Market: Regional Analysis

America is holding the first position in the market for non-sterile compounding pharmacy owing to the rising demand for customized medicine, increasing prevalence of chronic diseases such as diabetes, and rising number of hospital-based compounding pharmacies. As per the Center for Diseases Control and Prevention (CDC) in 2015, 30.3 million Americans, i.e. 9.4% of the population had diabetes. Additionally, 1.25 million American children and adults had type 1 diabetes.

Europe is the second largest non-sterile compounding pharmacy market across the globe. In Europe, growing awareness about compounding pharmaceutical products for the treatment of chronic diseases such as diabetes, drug allergies, and increasing number of prescriptions for the compounded medications propel the growth of the market. According to the European Academy of Allergy and Clinical Immunology (EAACI), around 2.6% hospitalization happens due to adverse drug effects, while the prevalence of drug allergy in the hospitalized patients is about 10% in the Europe.

Non-Sterile Compounding Pharmacy Market: Market Synopsis

The U.S. Pharmacopeia Convention (USP) formally defines compounding as ‘the preparation, mixing, assembling, altering, packaging, and labelling of a drug, drug-delivery device in accordance with a licensed practitioner's prescription, medication order, or initiative based on the practitioner/patient/ pharmacist/compounder relationship in the course of professional practice.’ Products manufactured by a compounding pharmacy are customized according to the patient need.

Get Discount Page @ https://www.marketresearchfuture.com/check-discount/4669 .

The market for non-sterile compounding pharmacy is driven by an increasing prevalence of chronic diseases such as diabetes, rising need for customized medicine and increasing geriatric population. Furthermore, the demand for anti-aging products that use custom compounded drugs is growing in the U.S. and Europe. However, the strict regulations governing the manufacturing of the compounded product and high prices restrain the market growth. The U.S. & Europe non-sterile compounding pharmacy market is expected to grow steadily at a CAGR of 2.65% during the forecast period.

List of Tables:

Table 1 U.S. & Europe Non-Sterile Compounding Pharmacy Market, By Product,
2014- 2023 (Usd Million) 39
Table 2 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Oral Medications,
By Region, 2014-2023 (Usd Million) 41
Table 3 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Topical Medications,
By Region, 2014-2023 (Usd Million) 42
Table 4 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Otologic/
Nasal Medication, By Region, 2014-2023 (Usd Million) 43
Table 5 U.S. & Europe Non-Sterile Compounding Pharmacy Market, By Application,
2014-2023 (Usd Million) 45
Table 6 U.S. & Europe Non- Sterile Compounding Pharmacy Market, By End User,
2014-2023 (Usd Million) 48
Table 7 U.S. & Europe Non- Sterile Compounding Pharmacy Market, By Region,
2014-2023 (Usd Million) 49
Table 8 U.S. Non- Sterile Compounding Pharmacy Market, By Region, 2014-2023 (Usd Million) 51
Table 9 U.S. Liquid Preparation Market, By Volume, 2014-2023 (Units) 51
Table 10 U.S. Syrups Market, By Volume, 2014-2023 (Units) 51

And more…

List of Figures:

FIGURE 1 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY PRODUCT MARKET SHARE,
FIGURE 2 U.S. & EUROPE NON- STERILE COMPOUNDING PHARMACY MARKET, BY APPLICATION, MARKET SHARE
FIGURE 3 U.S. AND EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET BY END USER, MARKET SHARE
FIGURE 4 MARKET STRUCTURE
FIGURE 5 RESEARCH PROCESS
FIGURE 6 FORECAST MODEL
FIGURE 7 VALUE CHAIN:NON-STERILE COMPOUNDING PHARMACY MARKET
FIGURE 8 PORTERS FIVE FORCES MODEL
FIGURE 9 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY PRODUCT,
2016 & 2023 (USD MILLION)
FIGURE 10 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY APPLICATION,
2014- 2023 (USD MILLION)
FIGURE 11 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET: COMPANY SHARE ANALYSIS
FOR THE KEY PLAYERS, 2016 (%)

Have Any Query, Ask to our Expert @ https://www.marketresearchfuture.com/enquiry/4669 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Sterile Compounding Pharmacy Market Mega Trends 2018 | By Product - Oral Medication, Topical Medication, Otologic/Nasal Medication and Foreseeing to 2023 here

News-ID: 1007452 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Compounding

NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global
Compounding Pharmacies Market 2020: Top Key Players Are Triangle Compounding Pha …
Industry Overview: Updated research report on Compounding Pharmacies Market by ‘Market Growth Insight’ delivers pivotal information on the market including drivers, restraints, challenges, and opportunities. The Compounding Pharmacies report is useful to business owners, manufacturers, distributors, suppliers, marketing personnel, strategists, and customers since it helps them to understand the current market scenario and make future planning, while considering the risks that are also mentioned in the report. The Compounding Pharmacies report
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc. Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured